Tanabe et al. reported that cancer-associated fibroblasts (CAFs) accumulated into tumor sites via CCL3–CCR5 axis, and that CCR5 blockage with maraviroc could suppress tumor growth in a mouse colitis-associated CRC model41. Here, CCR5 is linked to cancer.